14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 AKBA stock ended at $1.40. This is 6.04% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 13.04% from a day low at $1.38 to a day high of $1.56.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Jun 30, 2016 $7.48 $7.48 $7.48 $7.48 179 800
Jun 29, 2016 $7.42 $7.42 $7.42 $7.42 363 200
Jun 28, 2016 $7.67 $7.67 $7.67 $7.67 238 000
Jun 27, 2016 $7.24 $7.24 $7.24 $7.24 277 200
Jun 24, 2016 $7.47 $7.47 $7.47 $7.47 833 100
Jun 23, 2016 $7.79 $7.79 $7.79 $7.79 195 100
Jun 22, 2016 $7.33 $7.33 $7.33 $7.33 442 500
Jun 21, 2016 $7.41 $7.41 $7.41 $7.41 501 400
Jun 20, 2016 $7.58 $7.58 $7.58 $7.58 750 800
Jun 17, 2016 $7.95 $7.95 $7.95 $7.95 383 600
Jun 16, 2016 $8.56 $8.56 $8.56 $8.56 117 639
Jun 15, 2016 $8.49 $8.49 $8.49 $8.49 115 460
Jun 14, 2016 $8.35 $8.35 $8.35 $8.35 143 136
Jun 13, 2016 $8.41 $8.41 $8.41 $8.41 185 938
Jun 10, 2016 $8.37 $8.37 $8.37 $8.37 122 885
Jun 09, 2016 $8.48 $8.48 $8.48 $8.48 149 725
Jun 08, 2016 $8.66 $8.66 $8.66 $8.66 175 670
Jun 07, 2016 $8.60 $8.60 $8.60 $8.60 237 320
Jun 06, 2016 $8.76 $8.76 $8.76 $8.76 214 695
Jun 03, 2016 $8.84 $8.84 $8.84 $8.84 181 852
Jun 02, 2016 $9.08 $9.08 $9.08 $9.08 255 946
Jun 01, 2016 $8.99 $8.99 $8.99 $8.99 172 570
May 31, 2016 $8.91 $8.91 $8.91 $8.91 288 807
May 27, 2016 $8.80 $8.80 $8.80 $8.80 171 862
May 26, 2016 $8.83 $8.83 $8.83 $8.83 167 360
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT